Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Editorial
. 2020 Oct;9(5):2296-2298.
doi: 10.21037/tau-20-881.

Is pelvic prophylactic radiotherapy in prostate cancer just right?

Daniel Taussky  1 , Guila Delouya  1
Affiliations
Editorial

Is pelvic prophylactic radiotherapy in prostate cancer just right?

Daniel Taussky et al. Transl Androl Urol. 2020 Oct.
No abstract available

PubMed Disclaimer

Conflict of interest statement

Conflicts of Interest: Both authors have completed the ICMJE uniform disclosure form (available at http://dx.doi.org/10.21037/tau-20-881). DT reports grants from Sanofi, outside the submitted work. GD reports grants, personal fees and non-financial support from Janssen Canada, personal fees from Sanofi, personal fees and non-financial support from Bayer, personal fees from Astellas, personal fees from Elekta, personal fees from Ter Sera, personal fees from Abbvie, personal fees from Ferring, other from Progenics, outside the submitted work.

Comment on

References

    1. Sandler KA, Cook RR, Ciezki JP, et al. Prostate-only versus whole-pelvis radiation with or without a brachytherapy boost for Gleason grade group 5 prostate cancer: a retrospective analysis. Eur Urol 2020;77:3-10. 10.1016/j.eururo.2019.03.022 - DOI - PMC - PubMed
    1. Avkshtol V, Ruth KJ, Ross EA, et al. Ten-Year Update of a Randomized, Prospective Trial of Conventional Fractionated Versus Moderate Hypofractionated Radiation Therapy for Localized Prostate Cancer. J Clin Oncol 2020;38:1676-84. 10.1200/JCO.19.01485 - DOI - PMC - PubMed
    1. Roach M, Moughan J, Lawton CAF, et al. Sequence of hormonal therapy and radiotherapy field size in unfavourable, localised prostate cancer (NRG/RTOG 9413): long-term results of a randomised, phase 3 trial. Lancet Oncol 2018;19:1504-15. 10.1016/S1470-2045(18)30528-X - DOI - PMC - PubMed
    1. Pommier P, Chabaud S, Lagrange JL, et al. Is There a Role for Pelvic Irradiation in Localized Prostate Adenocarcinoma? Update of the Long-Term Survival Results of the GETUG-01 Randomized Study. Int J Radiat Oncol Biol Phys 2016;96:759-69. 10.1016/j.ijrobp.2016.06.2455 - DOI - PubMed
    1. Chen RC. Randomized Trials and the Goldilocks Problem. Eur Urol 2020;77:11-3. 10.1016/j.eururo.2019.05.002 - DOI - PubMed